Technology progression in plants used for food and medicine by Arntzen, Charles J.
53
Over the past 10,000 years, humans have affected crop evolution by selecting
and growing plants for dietary and medicinal purposes. Creation of the crops
that provide our present food supply has been a dynamic and rapid evolution-
ary process resulting from selection for palatability and for nutritional and
health-related traits. Comparatively less effort has been devoted to improve-
ment of therapeutic or pharmacological properties, although new technologies
are making this much more feasible. The first section of this report will focus
on New-World species of the Solanaceae (the potato/tomato/tobacco family)
to␣ illustrate selection processes we have used to create new foods, with
some␣ mention of the value of new DNA-based tools for future improvements.
Secondly, I will discuss biotechnological tools now being used to convert
wild␣ plants to “cultured materials” that may provide superior pharmaceuticals
such as anti-cancer agents. Lastly, the potential for using modern biotechnology
is discussed as a means of creating “modern herbal medicines,” e.g. crops as
sources of oral vaccines.
CROP DOMESTICATION—REMOVING TOXICITY
Potato (Solanum tuberosum) and its relatives evolved in the central Andes of
Peru and Bolivia. More than a hundred wild species of tuber-bearing Solanum
can still be found in the mountains of South America. Chemical analyses show
that these tubers contain many toxic chemicals, including glycoalkaloids
(which give a bitter taste), saponins, phytohemagglutinins, proteinase
inhibitors, sesquiterpene phytoalexins, and phenols. These chemicals provide
protection against attack by fungi, bacteria, and insects, and certainly also
deterred our ancestors from eating them because of with their bitter taste and
toxicity. About 6,000 years ago, a strategy for converting toxic potatoes to a
palatable foodstuff was developed, and is still reflected in customs of modern
Andeans when they collect wild tubers and make tunta. Bitter-tasting potatoes
are spread on the ground at high altitudes to freeze overnight, and then are
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walked upon to fragment them. Lying in the dry mountain air and going
through cycles of freezing and thawing results in a “freeze-dried” product that
is then placed in a depression along a running stream. The flowing water
leaches out over 90% of the toxins, leaving the tunta for consumption. (One
is␣ reminded of instant mashed potatoes, albeit with much less work involved
in␣ their preparation.)
It is likely that ancestral “farmers” tasted the potatoes they collected and
preserved and replanted any that were less bitter. This early domestication led
to preferred “varieties” that could be grown at lower altitudes, since they no
longer needed the dry, cold mountain nights for freeze drying. Several thousand
varieties of potatoes are grown today in the Andean region, of varied flavor and
nutritional value; they represent the trial-and-error selection of many, many
farming generations. By the late sixteenth century, early explorers of South
America who had developed a taste for the domesticated potato brought some
varieties to Europe, whence they were later transferred to North America and
other parts of the world. Today, potato is the world’s fourth most important food
crop (after wheat, maize, and rice); we can thank our American ancestors for
the “genetic improvement” that made this possible.
Scientists interested in how foraging humans developed agricultural societies
have documented other examples of crop domestication over the last 10,000
years. The introduction of new foods has also been studied, with examples of
slow acceptance. For example, tomatoes, which are in the same family as
potatoes and also originated in South America, have only recently been
regarded as edible. In the nineteenth century, Europeans and Americans
believed they were poisonous. (There was logic to this assumption; wild
tomatoes contain highly toxic compounds, especially alkaloids, much like the
American wild relative—black nightshade (Solanum nigrum )—which we still
avoid due to its toxicity. Early introductions of tomato to Europe may have
been for ornamental value related to pretty flowers and colorful fruit.) As
recently as 1820, the state of New York forbade tomato consumption; the edict
was changed when Colonel Robert Johnston announced that he would eat an
entire bag of them outside the courthouse in Salem, New Jersey. It is reported
that two thousand people turned up to watch him die, and a band played a
funeral march while Johnston ate the lot and announced: “This luscious, scarlet
apple will form the foundation of a great garden industry.” He was correct;
genetic improvement of tomatoes has led to a multitude of sizes, shapes, colors,
and tastes (Figure 1). Some of those known today as “heritage varieties” date
back to selections from the early 1900s.
UNINTENDED OUTCOMES OF TOXIN REMOVAL
The domestication of virtually all of the world’s major food crops has involved
the selection of varieties that have lost their genetic capacity to make toxic
chemicals. While this is clearly of advantage for human digestion, it leaves the
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plants with a greatly reduced defensive capacity against pathogens and
predators (fungi, bacteria, and insects). (Toxic chemicals are nature’s pesticides;
weeds, which often have a bitter taste due to the presence of these chemicals,
generally resist disease and predation better than crops.) About 300 years after
introduction into Europe, potatoes wre attacked by late-blight disease (caused
by the oomycete Phytophthora infestans) in the devastating Irish potato famine
of 1845 and 1846. Phytophthora had probably been a pathogen on other species,
but mutations allowed it to alter its host range to include potato, especially
“chemically weakened” domesticated varieties.
Agricultural specialists have developed alternative chemical strategies to
improve crop defenses against pathogens and predators. In the nineteenth
century, various “pesticide” formulations were developed in attempts to protect
Figure 1. Genetic diversity in tomatoes is evident in fruit size, color,
and␣ shape. Biochemical variability is less obvious, especially with respect
to␣ secondary metabolites such as toxic alkaloids.
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potatoes, grapes, and other crops. These included sprays containing copper
or␣ arsenic, or nicotine in tobacco juice. Nicotine, a toxic alkaloid, is similar in
chemistry to compounds found in other members of the Solanaceae, including
some in tomato and potato that have been “genetically reduced” during
domestication. (It is ironic that we genetically removed “defense” molecules
from some crops, and then sprayed them with analogous compounds to limit
disease and insect predation!) In the twentieth century, improvements in
chemical synthesis allowed the development of many new classes of pesticides.
In spite of very sizable expenditures by farmers who continue to purchase
pesticides to fight diseases and insects, pests are still the primary cause of yield
losses. We now know that many commercial pesticides mimic, at least partially,
the actions of the defense chemicals that were originally in our food crops,
but␣ have been lost during domestication. In recent decades, many agricultural
scientists have pursued the selective genetic restoration of “defense chemicals”
to our crops, but without their inclusion in harvested portions that are eaten.
This is a complex process, but one that is greatly aided by modern genomics
research that defines genes and genetic elements that regulate metabolic
pathways. It can be anticipated that the combined tools of DNA-based, marker-
assisted breeding and gene transfer will foster guided evolution for further
improvements in crop quality and resistance to pests and pathogens.
The power of new techniques is already apparent in the results of efforts of
crop breeders to modify domestic potatoes: genetically modified varieties are
now commercially available. One of the first targets was insect resistance, since
predation (especially by the Colorado potato beetle) is among the most
important reasons for yield losses, and prevention sometimes requires several
applications of insecticide. In addition, loss of harvested tubers to insect larvae
is a significant problem in developing countries lacking adequate storage
facilities. The strategy first used to create insect-resistant potatoes involved
transfer of a gene from a bacterium that is pathogenic to insect larvae, but
which is harmless to birds, fish, and mammals. The bacterium, Bacillus
thuringiensis, produces an insecticidal protein in nature (the Bt protein). When
an insect larva eats plant tissue containing the Bt protein, its digestive process
is␣ fatally interrupted. This approach offers reduction in crop losses and, in
parallel, less use of chemical insecticides.
SELECTION OF PLANTS FOR “VALUABLE TOXICITY”
In addition to developing food crops with reduced toxin content, our ancestors
used a trial-and-error approach to identify plants for treatment or prevention
of␣ disease. Herbal extracts have been used for thousands of years and still
comprise the primary medicinals used by nearly two thirds of the world’s
population. About 30% of “western” medicines utilize plant products in their
formulation or synthesis. Although our ancestors could not have described it
in␣ modern terms, we now know that they were selectively identifying plants or
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plant parts that contain complex chemicals that can directly modulate human
metabolism. With the advent of modern chemical analyses coupled with the
emerging tools of DNA-based genomic characterization of plants, the search for
new bioactive molecules is progressing rapidly.
One of the goals of cancer chemotherapy and prevention is the discovery of
compounds that are relatively selective of tumor cells and, therefore, have little
effect on healthy tissue. By extracting chemicals from many plant species and
analyzing the mixtures for activity in cancer-cell assays, we discovered that
certain triterpene saponins (called avicins) from the desert tree Acacia victoriae
are selectively toxic to tumor cells at very low doses (Joshi et al., in press).
To␣ extend this research to human clinical studies we developed a transformed
“hairy-root” culture system as a reliable means of production of avicins
(Figure␣ 2). Culture conditions have been optimized for root biomass produc-
tion, and we have identified putative triterpene “metabolic clusters” with
enhanced activity against tumor cells. This system provides sufficient material
for clinical trials, and also a means of correlating structure of individual
triterpene glycosides with specific target activity in mammalian cells.
Figure 2. A “hairy root” culture established by genetic transformation of
Acacia victoriae using Agrobacterium rhizogenes for gene transfer. These
cultures have the advantage of immortal root growth in fermentation tanks,
with uniform and predictable metabolic performance necessary for commer-
cial pharmaceutical production.
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To relate our studies of “avicins” to the broader picture of drug discovery, it is
noteworthy that plants contain tens of thousands of complex chemicals, many
of potential value as “yet to be discovered” biologically active molecules for use
as pharmaceuticals or nutraceuticals. This is a very active area of discovery
research in public-sector and industrial laboratories. As new prototype products
are identified, the tools of agricultural biotechnology will increasingly be used
to establish reliable and uniform sources of pharmaceutical supply.
NEXT GENERATION AGRICULTURAL BIOTECHNOLOGY PRODUCTS
Over the last decade, my colleagues and I have adapted the tools of plant
biotechnology to the area of vaccine technology. Our primary motivation came
from the need for less expensive vaccines in the developing world and for
technology to allow developing countries to rapidly expand in-country
manufacture of vaccines. According to the World Health Organization, more
than 5 million children in developing countries die each year from common
infectious diseases, predominantly those that cause diarrhea and respiratory
ailments. Although preventative medicine has progressed rapidly in the last
decade as biotechnology has been applied to create new vaccines, the new
products are comparatively expensive for developing countries. For this reason,
a novel strategy has been developed for vaccine production using transgenic
plants that contain genes derived from bacteria or viruses that are pathogenic to
humans. The “transgene” causes the plant to produce a protein that is the
“antigenic signature” of the disease. Using mice as a model, we have shown that
consumption of transgenic plant samples as food triggered an oral immune
response to the “signature” protein.
Research on plant-based vaccines has progressed to human clinical trials,
three of which have been conducted in the United States. All were conducted
after the Food and Drug Administration evaluated and approved the protocols.
Vaccines to prevent diarrhea were chosen for two early studies since it causes
approximately 2.5 million infant deaths annually, chiefly in the developing
world. The human studies have now been completed—Phase I trials that
verified the safety and efficacy of the approach (Figure 3).
To accomplish oral immunization of infants using transgenic food, it is
necessary to select an appropriate crop that can be grown in developing
countries, and which is eaten uncooked, to avoid destruction of the vaccine
proteins by heat. Accordingly, efforts are underway to develop vaccine-
synthesizing tomatoes and bananas. Current research is identifying ways to
prepare a dry formulation of vaccine-containing tomato extract using common
food processing technology, and to cause the appropriate proteins to accumu-
late in the banana fruit for infant vaccination with a food puree. In both cases,
our objective is to develop agricultural and food-based technologies that can
readily be adopted in developing countries.
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Figure 3. Human clinical trials have been conducted to test the
effectiveness of transgenic potatoes as oral vaccines. This volunteer,
shown eating raw potato, was part of a successful vaccine trial; plant
tissues were engineered to accumulate a specific protein normally
produced by a bacterium that causes severe diarrhea. When the potato
samples were eaten, the immune system of the volunteers responded by
production of antibodies specific to the bacterial protein, thereby
providing evidence for success of a “plant-derived oral vaccine.”
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The use of transgenic plants to produce and deliver oral vaccines also has
applicability as novel strategies for disease prevention in animals, thereby
improving the safety of our food supply, and stability of animal production.
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